Nobuyuki Shibukawa

Title: Nobuyuki Shibukawa: Innovator in Interferon Inducers

Introduction

Nobuyuki Shibukawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of interferon inducers. His work has the potential to impact the treatment of various viral infections.

Latest Patents

Shibukawa holds two notable patents related to interferon inducers. The first patent describes an interferon inducer isolated from plant tissue, which has an elemental analysis of H: 7.4±0.4%, C: 45.6±0.4%, N: 13.5±0.4%, P: 2.8±0.3%, and a molecular weight ranging from about 100,000 to about 3,000,000. This substance is believed to be a homogeneous polymer of protein and phosphoric acid, exhibiting excellent interferon inducing activity and low toxicity against various viruses. The production process involves extracting the active substance from the tissue of plants from the genus Artemisia and recovering it through ultrafiltration.

The second patent also focuses on an interferon inducer, with an elemental analysis of H: 8.5-8.7%, C: 48.8-49%, N: 6.3-6.5%, and P: 1.0-1.1%. This substance is characterized as a homogeneous polymer of protein and sugars, containing phosphoric acid. Similar to the first, it demonstrates significant antiviral activity and is produced by extracting from the genus Perilla. The recovery process is also achieved through ultrafiltration.

Career Highlights

Nobuyuki Shibukawa is affiliated with The Kitasato Institute, where he conducts his research and development work. His innovative approaches to pharmaceutical compositions have garnered attention in the scientific community.

Collaborations

Shibukawa has collaborated with notable colleagues, including Yasuhiko Kojima and Seishi Konno. Their combined expertise has contributed to advancements in the field of interferon inducers.

Conclusion

Nobuyuki Shibukawa's work in the development of interferon inducers showcases his commitment to advancing pharmaceutical science. His patents reflect significant innovations that may lead to effective treatments for viral infections.